Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Almåsbak

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology Research|June 15, 2016
CAR T Cell Therapy: A Game Changer in Cancer TreatmentHilde Almåsbak, Tanja Aarvak, Mohan C Vemuri
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2025
Engineering mRNA CAR-T Cells for Cancer ImmunotherapyHilde Almåsbak, Mouldy Sioud, Anne-Marie Rasmussen
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2010
Non-MHC-dependent redirected T cells against tumor cellsHilde Almåsbak, Marianne Lundby, Anne-Marie Rasmussen
Journal of Immunological Methods|December 9, 2003
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2Elisabeth Paus, Hilde Almåsbak, Ole P Børmer, et al.
Oncoimmunology|May 17, 2017
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces <i>in vivo</i> tumor growthElse M Inderberg, Sébastien Wälchli, Marit R Myhre, et al.
Cytotherapy|December 23, 2010
Transiently redirected T cells for adoptive transferHilde Almåsbak, Edith Rian, Hanna Julie Hoel, et al.
Cancer Immunology Research|February 21, 2018
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen ReceptorsVincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology Research|June 15, 2016
CAR T Cell Therapy: A Game Changer in Cancer TreatmentHilde Almåsbak, Tanja Aarvak, Mohan C Vemuri
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2025
Engineering mRNA CAR-T Cells for Cancer ImmunotherapyHilde Almåsbak, Mouldy Sioud, Anne-Marie Rasmussen
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2010
Non-MHC-dependent redirected T cells against tumor cellsHilde Almåsbak, Marianne Lundby, Anne-Marie Rasmussen
Journal of Immunological Methods|December 9, 2003
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2Elisabeth Paus, Hilde Almåsbak, Ole P Børmer, et al.
Oncoimmunology|May 17, 2017
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces <i>in vivo</i> tumor growthElse M Inderberg, Sébastien Wälchli, Marit R Myhre, et al.
Cytotherapy|December 23, 2010
Transiently redirected T cells for adoptive transferHilde Almåsbak, Edith Rian, Hanna Julie Hoel, et al.
Cancer Immunology Research|February 21, 2018
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen ReceptorsVincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, et al.
Pageof 1